Annual Operating Expenses
$20.62 M
+$7.08 M+52.30%
December 31, 2023
Summary
- As of February 7, 2025, EPRX annual total operating expenses is $20.62 million, with the most recent change of +$7.08 million (+52.30%) on December 31, 2023.
- During the last 3 years, EPRX annual operating expenses has risen by +$18.95 million (+1130.16%).
- EPRX annual operating expenses is now at all-time high.
Performance
EPRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$6.27 M
-$281.90 K-4.30%
September 1, 2024
Summary
- As of February 7, 2025, EPRX quarterly total operating expenses is $6.27 million, with the most recent change of -$281.90 thousand (-4.30%) on September 1, 2024.
- Over the past year, EPRX quarterly operating expenses has dropped by -$281.90 thousand (-4.30%).
- EPRX quarterly operating expenses is now -47.63% below its all-time high of $11.98 million, reached on December 31, 2023.
Performance
EPRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
EPRX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +52.3% | -4.3% |
| 3 y3 years | +1130.2% | +132.0% |
| 5 y5 years | +86.7% | +794.0% |
EPRX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.3% | -47.6% | +132.0% |
| 5 y | 5-year | at high | +1130.2% | -47.6% | +4733.0% |
| alltime | all time | at high | +1130.2% | -47.6% | +4733.0% |
Eupraxia Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.27 M(-4.3%) |
| Jun 2024 | - | $6.56 M(-2.1%) |
| Mar 2024 | - | $6.69 M(-44.1%) |
| Dec 2023 | $20.62 M(+52.3%) | $11.98 M(+80.9%) |
| Sep 2023 | - | $6.62 M(+16.0%) |
| Jun 2023 | - | $5.71 M(+61.5%) |
| Mar 2023 | - | $3.54 M(-50.6%) |
| Dec 2022 | $13.54 M(-9.1%) | - |
| Dec 2022 | - | $7.16 M(+102.2%) |
| Sep 2022 | - | $3.54 M(-25.7%) |
| Jun 2022 | - | $4.77 M(+75.5%) |
| Mar 2022 | - | $2.72 M(+0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $14.90 M(+788.6%) | $2.70 M(-31.9%) |
| Sep 2021 | - | $3.97 M(-1.1%) |
| Jun 2021 | - | $4.01 M(-2.5%) |
| Mar 2021 | - | $4.12 M(+3071.0%) |
| Dec 2020 | $1.68 M(-63.9%) | $129.80 K(-66.1%) |
| Sep 2020 | - | $383.00 K(-22.6%) |
| Jun 2020 | - | $495.10 K(-29.4%) |
| Mar 2020 | - | $701.70 K(+124.3%) |
| Dec 2019 | $4.64 M(-58.0%) | $312.80 K(-73.8%) |
| Sep 2019 | - | $1.19 M |
| Dec 2018 | $11.05 M(+188.0%) | - |
| Dec 2017 | $3.84 M | - |
FAQ
- What is Eupraxia Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual operating expenses year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly operating expenses year-on-year change?
What is Eupraxia Pharmaceuticals annual total operating expenses?
The current annual operating expenses of EPRX is $20.62 M
What is the all time high annual operating expenses for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual total operating expenses is $20.62 M
What is Eupraxia Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, EPRX annual total operating expenses has changed by +$7.08 M (+52.30%)
What is Eupraxia Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of EPRX is $6.27 M
What is the all time high quarterly operating expenses for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly total operating expenses is $11.98 M
What is Eupraxia Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, EPRX quarterly total operating expenses has changed by -$281.90 K (-4.30%)